Results Sirius red staining and hydroxyproline assays showed that splenectomy suppressed liver fibrogenesis in BALB/c mice. Reverse transcription PCR analysis of T helper type 1 (Th1) and T helper type 2 (Th2) cytokines demonstrated that splenectomy shifted the Th1/Th2 balance in the liver towards Th1 dominance. In SCID mice, the inhibitory effect on liver fibrosis was abrogated. The number of CD4
? T helper lymphocytes in the spleen decreased after liver injury. Green fluorescent protein positive (GFP ? ) splenocytes were transplanted into the spleens of syngeneic wild-type mice to trace their destination after fibrosis induction. GFP ? CD4 ? lymphocytes appeared in the liver after induction of fibrosis, and flow cytometry revealed the vast majority of them were Th2 lymphocytes. Transfer of splenocytes via the portal vein into syngeneic splenectomized mice cancelled the suppressive effect of splenectomy on liver fibrosis. Conclusions The present study demonstrated that Th2-dominant splenic lymphocytes migrate into the liver and promote liver fibrosis by shifting the cytokine balance towards Th2 dominance. Splenectomy suppresses the progression of fibrosis at least partly by restoring the Th1/Th2 balance. 
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Introduction
Sustained liver injury results in liver fibrosis regardless of the cause. Hepatic fibrosis is characterized by a progressive accumulation of fibrillar extracellular matrix proteins in the liver that distorts the hepatic architecture and may eventually result in liver cirrhosis [1] . Since the progression of liver fibrosis is directly associated with complications in chronic liver diseases, understanding the pathophysiological mechanisms of liver fibrosis and intervention in the fibrotic process is crucial for improving the prognosis of patients with chronic liver diseases. Hypersplenism is a major complication in patients with advanced liver fibrosis. For those patients, splenectomy is beneficial and often indicated as it increases the platelet count and makes antiviral therapy or invasive treatment feasible [2] . Moreover, clinical observations have revealed that splenectomy not only increases the platelet count, but also improves liver function [3, 4] . In addition, some experimental studies have shown that splenectomy suppresses the progression of liver fibrosis. The underlying mechanisms are largely unknown, although a few studies have proposed explanations for this phenomenon [5] [6] [7] . The spleen plays important roles in the immune system. Specifically, B cells and plasma cells mature in the spleen, and have key functions in humoral immunity. Moreover, T cells and the cytokines they produce play important roles in modifying the maturation process of these lymphocytes. Importantly, the immune system can affect the progression of liver fibrosis; for instance, strain-specific differences in murine hepatic fibrotic responses are mediated by divergent T helper cytokine responses [8] . In addition, immunosuppressants differently modulate hepatic fibrotic responses in mice and humans [9, 10] . These observations have led us to the hypothesis that the spleen modulates liver fibrosis through its immunological functions. The present study aimed to investigate the role of the spleen in liver fibrosis, with particular focus on its immunological functions.
Materials and methods
Animals
BALB/c, C57BL/6, severe combined immunodeficiency (SCID), and C57BL/6-Tg(CAG-EGFP)C14-Y01-FM131Osb (''green mice'') male mice were purchased at 10 weeks of age from Japan SLC (Shizuoka, Japan) and CLEA Japan (Tokyo, Japan). After acclimation for 7 days, the mice were divided into sham-operation and splenectomy groups. Splenectomies were performed under pentobarbital anaesthesia (50 mg/kg) as previously described [5] . Splenic arteries and veins were ligated twice with 6-0 nylon sutures with a minimal incision on the upper abdominal midline. Sham-operation mice underwent a laparotomy without splenectomy. The protocol for animal handling was reviewed and approved by the Animal Care and Use Committee of Kyoto University.
Experimental liver fibrosis models Liver fibrosis was induced by repetitive injections of carbon tetrachloride (CCl 4 ) or thioacetamide (TAA). In the CCl 4 -induced liver fibrosis model, each mouse was subjected to intraperitoneal injections of CCl 4 (0.5 lL/g body weight; 1:4 dilution with corn oil) or corn oil as a control twice a week for 6 weeks [11] . Livers were harvested 7 days after the last injection. TAA-induced liver fibrosis was induced by intraperitoneal injections with escalating doses of TAA or normal saline as a control three times a week for 6 weeks (first dose, 100 mg/kg, weeks 1-2, 200 mg/kg; weeks 3-4, 300 mg/kg; weeks 4-6, 400 mg/ kg), as previously described [12] . Livers were harvested 3 days after the last injection. Bile duct ligation (BDL) was performed by surgical ligation of the common bile duct, as previously described [13] . The common bile duct was ligated three times with 6-0 nylon sutures under pentobarbital anaesthesia (50 mg/kg). Sham-operation mice underwent laparotomy without ligation of the common bile duct. Mice were killed for analysis at 10 days and 3 weeks after the operation.
Sirius red staining
Formalin-fixed specimens were embedded in paraffin, sliced with a thickness of 4 lm, and mounted on silanized glass slides. Sirius red staining was performed as previously described [13] . Ten nonoverlapping fields per mouse at a final magnification of 9100 were randomly selected and photographed. The Sirius red positive area was quantified using an image analysis software package (Image J; National Institutes of Health).
Immunofluorescence staining
The specimens were fixed in 4 % paraformaldehyde, embedded in OCT compound, and sliced with a thickness of 5 lm. Antigen retrieval was performed by incubation in citric acid buffer at 90°C, for 20 min. After blocking, the sections were incubated with a primary antibody against asmooth muscle actin (a-SMA; ab5694; Abcam, Cambridge, UK), CD4 (IH95-0042; eBioscience, San Diego, CA, USA), CD45RC (ab3135; Abcam), or green fluorescent protein (GFP; A1122; Invitrogen, Carlsbad, CA, USA) at 1:100 dilution overnight at 4°C, and were then incubated with a corresponding secondary antibody at room temperature for 1 h. The CD4-positive area was evaluated as a percentage using Image J.
Hydroxyproline content measurement Liver tissues were homogenized in ice-cold distilled water (1 mL). Subsequently, 125 lL of 50 % trichloroacetic acid was added, and the homogenates were incubated on ice for 30 min. The precipitated pellets were hydrolysed for 24 h at 110°C in 6 N HCl. After hydrolysis, the samples were Fig. 1 Splenectomy suppresses the progression of liver fibrosis in a CCl 4 -induced liver injury mouse model. BALB/c mice were divided into sham-operation and splenectomy groups and received injections of CCl 4 (n = 7 mice per group) or corn oil (n = 6 mice per group). a Liver fibrosis was evaluated by Sirius red staining. Original magnification 940. b The Sirius red positive area was quantified as a percentage using Image J. c Collagen deposition was quantified by measuring the hydroxyproline content in the liver. d Quantitative reverse transcription PCR (qRT-PCR) was performed to measure messenger RNA (mRNA) expression levels of Col1a1 (which encodes type I collagen a 1 ). Gapdh (which encodes glyceraldehyde 3-phosphate dehydrogenase) was used as an internal control. e Activation of hepatic stellate cells was evaluated by immunofluorescence staining for a-smooth muscle actin (a-SMA; which is encoded by Acta2). Original magnification 9100. f Hepatic expression levels of Acta2 mRNA were measured using qRT-PCR. Gapdh was used as an internal control. The mean ± the standard deviation is shown. Asterisks indicate statistically significant differences (P \ 0.05) determined by the Mann-Whitney U test. Sp(-) sham-operation group, Sp(?) splenectomy group filtered, neutralized with 10 N NaOH, and oxidized with chloramine-T (Sigma-Aldrich, St Louis, MO, USA) for 25 min at room temperature. The reaction mixture was incubated in Ehrich's perchloric acid solution at 65°C for 20 min and then cooled to room temperature. Sample absorbance was measured at 560 nm in duplicate. Purified hydroxyproline (Sigma-Aldrich) was used as a standard. The hydroxyproline content was expressed as nanograms of hydroxyproline per milligram of liver.
Quantitative reverse transcription PCR analysis Total RNA was extracted from liver samples using TRIzol (Invitrogen, Tokyo, Japan) and RNeasy Mini kits with oncolumn DNA digestion (Qiagen, Tokyo, Japan). Total RNA was reverse transcribed to complementary DNA using an Omniscript reverse transcription kit (Qiagen, Valencia, CA, USA). We performed quantitative reverse transcription PCR (qRT-PCR) with gene-specific PCR primers (Table S1 ) and SYBR Green I master reaction mix using a LightCycler 480 II instrument (Roche Diagnostics, Basel, Switzerland). The relative abundance of the target genes was determined by comparison with a standard curve and was normalized to the abundance of Gapdh as an internal control using the LightCycler 480 software (version 1.5).
Isolation of hepatic lymphoid cells
Hepatic lymphoid cells were isolated from murine livers by a method described previously [13, 14] . Livers were minced into small fragments and washed free of blood in cold phosphate-buffered saline (PBS). Fragments were passed through a 100-lm steel mesh. The cell suspension was filtered through a nylon mesh (BD Falcon cell strainer; BD Biosciences) to remove tissue debris. Filtered cells were centrifuged at 50g for 1 min to remove the hepatocyte fraction. The remaining nonparenchymal cell fraction was collected, washed, and resuspended in PBS. Leukocytes were isolated by density-gradient centrifugation (Histopaque-1077; Sigma-Aldrich). Cell viability was assessed by trypan blue staining.
Isolation of lymphocytes from spleen
Spleens were minced through a nylon mesh (BD Falcon cell strainer; BD Biosciences) to obtain single-cell suspensions in PBS as previously described [15] . Erythrocytes were lysed by incubation in lysis buffer (00-4333-57; eBioscience, San Diego, CA, USA) for 4 min at room temperature. Following these procedures, lymphocytes were washed twice in PBS by centrifugation at 300g at 4°C and were resuspended in PBS.
Flow-cytometric analysis
Hepatic lymphoid cell isolation from liver tissues and staining for flow cytometry were performed as described in [14] . In brief, lymphoid cells were stained with anti-CD4 (BD Pharmingen 553051; BD Biosciences, San Diego, CA, USA) and anti-CD45RC (BD Pharmingen 557357; BD Biosciences San Diego, CA, USA) mouse antibodies labelled with allophycocyanin and phycoerythrin, respectively. Three-colour flow-cytometric analyses were performed using a BD Accuri C6 flow cytometer (BD Biosciences, San Jose, CA, USA).
Statistical analysis
Quantitative data are expressed as the mean ± the standard deviation. For statistical analysis, we used the MannWhitney U test. P values less than 0.05 were regarded as statistically significant.
Results
Splenectomy suppresses progression of liver fibrosis induced by CCl 4 and TAA in mice Liver fibrosis was induced by repetitive administration of CCl 4 for 6 weeks, and hepatic collagen deposition was evaluated by Sirius red staining of the liver sections. In the corn oil control groups, Sirius red staining demonstrated no fibrous regions, except in the portal areas. Collagen deposition was observed in the livers of mice that received CCl 4 for 6 weeks. The area of fibrous changes in the CCl 4 c Fig. 2 Splenectomy modifies the T helper type 1 (Th1)/T helper type 1 (Th2) balance in the liver in a CCl 4 -induced liver injury model. Quantitative reverse transcription PCR (qRT-PCR) was performed to measure hepatic messenger RNA (mRNA) expression levels of a Ifng, Il2, and Il12a/Il12b (which encode Th1 cytokines) and b Il4 and Il13 (which encode Th2 cytokines). Gapdh was used as an internal control. c The ratio of the mRNA expression levels of Ifng (Th1) to Il4 (Th2) in each mouse was compared between the CCl 4 sham-operation group and the CCl 4 splenectomy group. d The mRNA expression levels of Tgfb1 (which encodes a potent profibrogenic cytokine) were measured by qRT-PCR. e Intrahepatic lymphocytes were isolated from CCl 4 splenectomy and sham-operation mice and were subjected to flow-cytometric analysis for expression of CD4 and CD45RC. The statistical result found in at least seven mice is shown. f Double immunofluorescence staining for CD45RC (green) and CD4 (red). The number of CD4
? cells and CD45RC ? CD4 ? cells were counted under a magnification of 9100, and the proportion of CD45RC ?
CD4
? cells among CD4 ? cells in the liver is shown. (n = 7 for CCl 4 groups, n = 6 for control groups). The mean ± the standard deviation is shown. *P \ 0.05, **P \ 0.01, ***P \ 0.001,
splenectomy group, TGF transforming growth factor splenectomy group was markedly attenuated compared with that of the CCl 4 sham-operation group (Fig. 1a) . The Sirius red positive area quantified by Image J was significantly reduced in the CCl 4 splenectomy group compared with the CCl 4 sham-operation group (3.82 ± 1.29 % vs 5.79 ± 1.43 %; P = 0.018; Fig. 1b) . The hepatic content of hydroxyproline, a biochemical marker of collagen accumulation, was elevated to 344 ± 34.2 ng/mg liver in the CCl 4 sham-operation group (Fig. 1c) . Comparatively, it was reduced to 274 ± 64.7 ng/mg liver in the CCl 4 splenectomy group, resulting in a statistically significant difference between the two groups (P = 0.018). Hepatic expression of Col1a1 (which encodes type I collagen a 1 ) evaluated by qRT-PCR was increased by 8.1-fold in the CCl 4 sham-operation group as compared with the corn oil group (Fig. 1d) . By comparison, Col1a1 expression was suppressed by 4.5-fold in the CCl 4 splenectomy group (P = 0.026). Activation of hepatic stellate cells was evaluated by immunostaining for a-SMA. Immunostaining for a-SMA in the CCl 4 sham-operation group demonstrated a significant increase in the number of a-SMA-positive cells. The number of a-SMApositive cells in the CCl 4 splenectomy group was lower than in the CCl 4 sham-operation group (Fig. 1e) . Similarly, hepatic expression of Acta2 (which encodes a-SMA) was significantly lower in the CCl 4 splenectomy group than in the CCl 4 sham-operation group (P = 0.038; Fig. 1f ).
The effect of splenectomy on liver fibrosis was also investigated using the TAA-induced liver injury model (Fig. S1 ). Sirius red staining demonstrated that collagen deposition in the TAA splenectomy group was significantly decreased compared with that in the TAA sham-operation group. The ratio of the fibrous area in the TAA splenectomy group was reduced compared with that in the TAA sham-operation group (6.62 ± 1.65 % vs 8.84 ± 0.82 %; P = 0.007). The hydroxyproline content was elevated to 277 ± 59.7 ng/mg liver in the TAA sham-operation group and was reduced to 221 ± 24.3 ng/mg liver in the TAA splenectomy group (P = 0.038). Hepatic expression of Col1a1 was suppressed in the TAA splenectomy group compared with the TAA sham-operation group (P = 0.038). Immunostaining for a-SMA demonstrated that the number of a-SMA-positive cells in the TAA splenectomy group was lower than that in the TAA shamoperation group. Hepatic expression of Acta2 was also suppressed in the TAA splenectomy group compared with the TAA sham-operation group (P = 0.026).
These results indicate that splenectomy suppressed collagen synthesis in the liver and alleviated liver fibrosis in the CCl 4 -induced and TAA-induced liver injury models.
We also investigated the effect of splenectomy in the BDL-induced liver injury model (Fig. S2) . Sirius red staining demonstrated remarkable fibrotic changes in the BDL-induced liver injury model. In contrast to the toxininduced liver fibrosis model, the fibrotic area was not different between the BDL sham-operation group and the BDL splenectomy group at both 10 days and 3 weeks after BDL (10 days, 7.97 ± 1.82 % vs 7.47 ± 2.28 %, P = 0.779; 3 weeks, 9.51 ± 1.67 % vs 8.25 ± 2.23 %, P = 0.456). The hydroxyproline content was also similar between the two groups (10 days, 181 ± 32.9 ng/mg liver vs 165 ± 42.8 ng/mg liver, P = 0.463; 3 weeks, 418 ± 83.2 ng/mg liver vs 451 ± 200 ng/mg liver, P = 0.209). In addition, hepatic expression of Col1a1 and Acta2 was comparable between the two groups (10 days, P = 0.902 and P = 0.165, respectively; 3 weeks, P = 0.902 and P = 0.383; respectively).
Splenectomy modifies the T helper type 1/T helper type 2 balance in toxin-induced liver fibrosis models
We analysed the effect of splenectomy on the inhibition of fibrotic responses induced in toxin-induced liver injury models, especially focusing on the T helper type 1 (Th1)/ T helper type 2 (Th2) balance. Liver fibrosis was induced by repetitive administration of CCl 4 for 6 weeks, and livers were harvested 7 days after the last injection. Expression of Ifng mRNA (Ifng encodes interferon-c, a typical Th1 cytokine) was increased by 5.0-fold in the CCl 4 sham-operation group in comparison with the corn oil control group. Expression of Ifng mRNA was further enhanced by 8.2-fold in the CCl 4 splenectomy group (P = 0.038; Fig. 2a) . Similarly, expression of Il2 [which encodes interleukin (IL)-2] and Il12a/Il12b (which encode IL-12) mRNA was increased by 2.6-fold and 1.8-fold in the CCl 4 sham-operation group, and this increase was further enhanced by 5.4-fold and 2.6-fold, respectively, in the CCl 4 splenectomy group (Il2, P = 0.038; Il12a/Il12b, P = 0.038; Fig. 2a ). In the CCl 4 sham-operation group in comparison with the corn oil group, expression of Il4 mRNA (Il4 encodes IL-4, a representative Th2 cytokine) was increased by 4.2-fold. In contrast to the Th1 cytokines, Il4 mRNA expression was suppressed by 2.4-fold in the CCl 4 splenectomy group (P = 0.038; Fig. 2b) . Similarly, Il13 mRNA expression was increased by 13-fold in the CCl 4 sham-operation group, and this increase was inhibited by 2.2-fold after splenectomy (P = 0.038; Fig. 2b ). The ratio of Ifng (Th1) to Il4 (Th2) mRNA expression in each mouse was increased by 4.7-fold in the CCl 4 splenectomy group compared with the CCl 4 sham-operation group (P = 0.038; Fig. 2c ). The expression levels of Tgfb1 (which encodes transforming growth factor b 1 , one of the most potent profibrogenic cytokines) did not differ between the CCl 4 splenectomy and CCl 4 sham-operation groups [16] (P = 0.383; Fig. 2d ). We also evaluated Th1 and Th2 cytokine expression from lymphocytes isolated from livers (Fig. S3) . Similarly to the results obtained from the whole liver tissue, Th1 cytokines were upregulated whereas Th2 cytokines were downregulated in the CCl 4 splenectomy group in comparison with the CCl 4 sham-operation group. The ratio of Ifng to Il4 mRNA expression was increased by 2.5-fold in the CCl 4 splenectomy group compared with the CCl 4 sham-operation group (P = 0.0082). The Th1/Th2 balance in the liver was also evaluated, on the basis of different CD45RC expression profiles between Th1 and Th2 lymphocytes [17, 18] Fig. 2f ).
We also investigated the change in the liver Th1/Th2 balance resulting from splenectomy in the TAA-induced liver injury model (Fig. S4) . The expression levels of Ifng, Il2, and Il12a/Il12b mRNA were increased by 3.8-, 3.0-, and 2.8-fold, respectively, in the TAA sham-operation group in comparison with the control saline group. The expression of Ifng, Il2, and Il12a/Il12b mRNA was enhanced by 5.5-, 7.5-, and 5.3-fold, respectively, in the TAA splenectomy group (Ifng, P = 0.038; Il2, P = 0.038; Il12a/Il12b, P = 0.038). In contrast, the expression levels Fig. 3 Suppressive effect of splenectomy on liver fibrosis is abrogated in immunodeficient severe combined immunodeficiency (SCID) mice. SCID mice were divided into sham-operation and splenectomy groups, and received injections of CCl 4 (n = 7 mice per group) or corn oil (n = 6 mice per group). a Liver fibrosis was evaluated by Sirius red staining. Original magnification 940. b The Sirius red positive area was quantified as a percentage using Image J. c Collagen deposition was quantified by measuring the hydroxyproline content in the liver. d Quantitative reverse transcription PCR (qRT-PCR) was performed to measure messenger RNA (mRNA) expression levels of Col1a1. Gapdh was used as an internal control. e Activation of hepatic stellate cells was evaluated by immunofluorescence staining for a-smooth muscle actin (a-SMA). Original magnification 9100. f Hepatic expression levels of Acta2 mRNA were measured by qRT-PCR. Gapdh was used as an internal control. The mean ± the standard deviation is shown. ns not significant, Sp(-) shamoperation group, Sp(?) splenectomy group of Il4 and Il13 mRNA were increased by 5.2-and 7.7-fold in the TAA sham-operation group compared with the saline group. Moreover, their expression levels were inhibited by 4.2-and 3.3-fold, respectively, in the TAA splenectomy group (Il4, P = 0.038; Il13, P = 0.026). The ratio of Ifng to Il4 mRNA expression was increased by 3.0-fold in the TAA splenectomy group compared with the TAA shamoperation group (P = 0.007). The expression level of Tgfb1 was not altered by splenectomy in the TAA-induced liver injury model (P = 0.805). The proportion of CD45RC high CD4 ? lymphocytes among CD4 ? lymphocytes in the TAA splenectomy group measured by flow cytometry was increased compared with that in the TAA sham-operation group (39.8 ± 2.9 % vs 21.2 ± 7.1 %). The ratio of CD45RC
? CD4 ? cells to CD4 ? cells was also increased in the TAA splenectomy group compared with the TAA sham-operation group, as demonstrated by immunostaining (35.2 ± 4.84 % vs 19.6 ± 3.58 %; P = 0.0002). Taken together, these results showed that splenectomy shifted the Th1/Th2 balance in the liver towards Th1 dominance in the toxin-induced liver fibrosis models.
In the BDL-induced liver injury model, there was no statistical difference in the expression levels of Ifng and Il4 mRNA between splenectomy and sham-operation groups at both 10 days and 3 weeks after BDL (Fig. S5) .
Effect of splenectomy is abrogated in immunodeficient SCID mice
Immunodeficient SCID mice were used to determine if immunological mechanisms were involved in the effect of splenectomy on liver fibrosis observed in wild-type mice. Although liver fibrosis was similarly induced with CCl 4 in SCID mice as in wild-type mice, the inhibitory effect of splenectomy on liver fibrosis was not observed in SCID mice (Fig. 3a) . In addition, the fibrotic area did not differ between CCl 4 splenectomy and sham-operation groups (8.12 ± 1.71 % vs 7.97 ± 1.57 %, P = 0.902; Fig. 3b ). The hepatic hydroxyproline content was similarly elevated in the CCl 4 splenectomy and sham-operation groups (457 ± 92.8 ng/mg liver vs 454 ± 81.4 ng/mg liver, P = 0.902; Fig. 3c) . The hepatic expression level of Col1a1 was not affected by splenectomy (P = 0.165; Fig. 3d ). Furthermore, splenectomy had no effect on hepatic expression of a-SMA, as demonstrated by immunostaining (Fig. 3e) and qRT-PCR (P = 0.535; Fig. 3f) .
Next, we evaluated the influence of splenectomy in the immunodeficient SCID mice on cytokine expression in our CCl 4 -induced liver fibrosis model. As expected, the expression levels of Ifng and Il4 mRNA were not influenced by splenectomy in SCID mice (Fig. 4a, b) . The ratio of Ifng to Il4 mRNA in each SCID mouse was comparable between the CCl 4 splenectomy and sham-operation groups (P = 0.902; Fig. 4c ). Tgfb1 mRNA expression levels showed no differences between the CCl 4 splenectomy and sham-operation groups (P = 0.383; Fig. 4d ).
Number of CD4
? cells in spleen is reduced in toxininduced liver fibrosis models Pathophysiological changes in the spleen of toxin-induced liver fibrosis model mice were evaluated to elucidate the mechanisms by which splenectomy suppressed liver fibrosis and modified the Th1/Th2 balance in the liver. Histological examination of spleens by haematoxylin and eosin staining revealed no structural changes between the control group and toxin-induced liver injury groups (Fig. 5a ). In the CCl 4 -induced liver injury model, we evaluated the serial CD4 ? cell counts in the spleen. Immunostaining for the T helper lymphocyte marker CD4 demonstrated a time-dependent decrease in CD4
? cell numbers (Fig. 5b) . The CD4-positive area was 8.43 ± 0.82 % before CCl 4 treatment, and it was 4 groups, n = 6 for control groups). The mean ± the standard deviation is shown. IFN interferon, IL interleukin, ns not significant, Sp(-) shamoperation group, Sp(?) splenectomy group, TGF transforming growth factor reduced to 4.49 ± 0.80 % and 3.18 ± 0.26 % after CCl 4 treatment for 3 and 6 weeks, respectively (3 weeks, P = 0.0043; 6 weeks, P = 0.0040; Fig. 5c ). Cd4 mRNA expression was also decreased by 0.75-and 0.58-fold after CCl 4 treatment for 3 and 6 weeks, respectively (3 weeks, P = 0.030; 6 weeks, P = 0.0039; Fig. 5d ). The proportion ? cells among total splenic cells is shown. The mean ± the standard deviation of values found in at least six mice is shown. *P \ 0.05, **P \ 0.01, ***P \ 0.001 of CD4
? lymphocytes to total splenic cells showed a timedependent decrease after CCl 4 treatment (15.4 ± 0.67 % before CCl 4 treatment, 12.2 ± 1.39 % at 3 weeks after CCl 4 treatment, and 8.54 ± 2.65 % at 6 weeks after CCl 4 treatment; Fig. 5e ). Similar findings were obtained in the TAAinduced liver injury model (Fig. S6) .
The CD4 ? cells accumulated in the liver after toxininduced liver injuries as demonstrated by the increase of the CD4
? area and Cd4 mRNA expression in the liver (Fig. S7) . Splenectomy slightly reduced the accumulation of CD4
? cells, although the difference did not reach statistical significant.
Splenic CD4
? cells migrate to the liver in the CCl 4 -induced liver injury model
The decrease in the number of T helper cells in the spleen prompted us to explore their fate after CCl 4 -induced liver injury. For this purpose, we isolated splenic cells from C57BL/6-Tg mice ubiquitously expressing an enhanced green fluorescent protein (GFP) [19] . The GFP ? splenic cells were transplanted into the spleen of syngeneic wildtype mice, and liver injury was induced by CCl 4 . Livers were examined on the days following the injection of the first, third, and fifth doses of CCl 4 . The migration of spleen-derived T helper cells in the liver was evaluated by GFP and CD4 immunostaining.
In the control groups, GFP ? cells were scarcely seen in the liver, and they were almost negative for CD4 (Fig. S8a) . In the CCl 4 -induced liver injury model, we observed a time-dependent increase in the number of GFP ? cells in the liver (Fig. 6a) . Immunostaining for CD4 revealed that the CD4
? cell count was also increased in a time-dependent manner (Fig. S8b) . Furthermore, the number of GFP ? CD4 ? cells (spleen-derived T helper lymphocytes) was time-dependently increased (three doses, 6.9 ± 0.4/9100 high-power field, five doses, 11.1 ± 1.1/ 9100 high-power field). The proportion of GFP ? cells among the CD4
? cells in the liver was 24.5 ± 1.72 % and 22.4 ± 1.62 % after three and five injections of CCl 4 , respectively (Fig. S8c) . To exclude the possibility that circulating GFP ? lymphocytes, not splenic GFP ? lymphocytes, were the source of GFP ? lymphocytes in the liver, we splenectomized mice 20 min after inoculation of the spleen with GFP ? splenocytes, and determined whether GFP ? lymphocytes appeared in the liver after fibrosis induction. Immunostaining showed that there were few GFP ? CD4 ? cells in the liver (Fig. 6a) , indicating that the major source of GFP ? lymphocytes appearing in the liver was not circulating GFP ? lymphocytes. GFP ? CD4 ? cells (spleen-derived T helper lymphocytes) in the liver were analysed for CD45RC expression by flow cytometry. The percentage of Th2 (CD45RC low )
lymphocytes was almost 100 % in GFP ? CD4 ? cells, whereas it was 88.0 ± 5.2 % in GFP -CD4 ? cells, indicating that T helper lymphocytes migrating from the spleen were Th2 dominant compared with the resident T lymphocytes in the liver (Fig. 6b) .
Transfer of splenocytes cancels the suppressive effect of splenectomy on liver fibrosis
The contribution of Th2-dominant splenic lymphocytes to liver fibrosis was investigated by adoptive transfer of isolated splenocytes to splenectomized mice. In this experiment, we evaluated liver fibrosis in the 3-week CCl 4 model (not the 6-week model) considering a short life span of injected splenic lymphocytes. Sirius red staining demonstrated that collagen deposition in the splenocyte-transferred CCl 4 splenectomy group was significantly enhanced compared with that in the PBS-injected CCl 4 splenectomy group, and it was comparable to that in the CCl 4 sham-operation group (Fig. 7a, b) . The hydroxyproline content was also elevated in the splenocyte-transferred CCl 4 splenectomy group compared with the PBS-injected CCl 4 splenectomy group (282 ± 74.1 ng/mg vs 234 ± 13.5 ng/mg, P = 0.026; Fig. 7c ). The expression level of Col1a1 was enhanced in the splenocyte-transferred CCl 4 splenectomy group compared with the PBS-injected CCl 4 splenectomy group (P = 0.026; Fig. 7d ). Hepatic expression of a-SMA was also enhanced in the splenocyte-transferred CCl 4 splenectomy group compared with the PBS-injected CCl 4 splenectomy group, as demonstrated by immunostaining (Fig. 7e) and qRT-PCR (P = 0.030; Fig. 7f ). These results demonstrated that transfer of splenocytes cancelled the suppressive effect of splenectomy on liver fibrosis.
Discussion
This study demonstrates that splenectomy inhibited toxininduced liver fibrosis in mice. A few experimental studies have shown that splenectomy suppressed liver fibrosis; however, the mechanisms underlying this phenomenon are largely unknown [5] [6] [7] . In the present study, we focused on the immunological implication of the spleen. The spleen is a lymphoid organ where lymphocytes mature. In addition, the spleen is directly connected to the liver via the splenic and portal veins and is an important constituent of the portal system. Therefore, it is plausible that the spleen influences the immunological status of the liver. In this study, splenectomy modified the balance of Th1/ Th2 cytokine expression towards Th1 dominance in the liver in CCl 4 -induced and TAA-induced liver fibrosis models. Previous studies have revealed that Th1 cytokines Gapdh was used as an internal control. e Activation of hepatic stellate cells was evaluated by immunofluorescence staining for a-smooth muscle actin (a-SMA). Original magnification 940. f Hepatic expression levels of Acta2 mRNA were measured using qRT-PCR. Gapdh was used as an internal control. The mean ± the standard deviation of values obtained in seven mice is shown. *P \ 0.05, **P \ 0.01, ns not significant, Sp(-) sham-operation group, Sp(?) splenectomy group have a suppressive effect on liver fibrosis. In particular, interferon-c is a potent inhibitor of the activation of hepatic stellate cells [20, 21] . By comparison, Th2 cytokines such as IL-4 and IL-13 promote activation of hepatic stellate cells and progression of liver fibrosis [16, 22, 23] . Therefore, our results suggest that the suppressive effect of splenectomy on liver fibrosis is mediated by an altered Th1/Th2 balance. To verify our hypothesis, we used immunodeficient SCID mice lacking functional lymphocytes [24] . In SCID mice, the suppressive effect on liver fibrosis, as well as the influence on the Th1/Th2 balance following splenectomy, was abrogated. These results strongly suggest that the modified Th1/Th2 cytokine balance following splenectomy observed in wild-type mice plays a causative role in the inhibition of liver fibrosis.
Interestingly, SCID mice lacking profibrotic Th2 lymphocytes showed liver fibrosis in response to CCl 4 to the same extent as or to an even higher extent than immunocompetent wild-type mice. Although the significance of lymphocyte proinflammatory and profibrotic properties has been well recognized, recent studies have demonstrated that there are lymphocyte subsets that regulate and control inflammatory response, such as regulatory T cells or cd T cells. For example, deficiency in regulatory T cells aggravates the progression of liver fibrosis [25] . We suppose that the lack of an immunomodulatory response by these lymphocytes in SCID mice might have contributed to enhancement of the fibrogenic response, although this is only speculation and needs to be investigated further.
Previous studies have implied other antifibrotic mechanisms mediated by splenectomy. For instance, it was suggested that platelets themselves could inhibit the development of liver fibrosis and that splenectomy exerted an antifibrotic effect via thrombocytosis [5, 6] . Comparatively, Akahoshi et al. [7] proposed that the loss of spleenderived transforming growth factor b 1 mediated the inhibitory effect of splenectomy on liver fibrosis. Decreases in portal flow and portal pressure are other possible mechanisms of the antifibrotic effect of splenectomy. Although our study did not preclude the aforementioned mechanisms, our observation that the splenectomy-mediated antifibrotic effect was abrogated in SCID mice strongly supports the proposal that immunological mechanisms are involved in this phenomenon.
We explored the mechanisms by which splenectomy modifies the Th1/Th2 balance in the liver. We observed that the number of CD4
? cells (T helper lymphocytes) in the spleen was dramatically decreased after liver injury. In contrast, the number of CD4
? cells was increased in the liver. These observations led us to speculate that T helper lymphocytes in the spleen migrated to the liver in response to liver injury. To examine our hypothesis, we isolated GFP ? splenic cells from C57BL/6-Tg(CAG-EGFP)C14-Y01-FM131Osb mice and transplanted them into the spleen of syngeneic wild-type mice. After CCl 4 -induced liver injury, we observed time-dependent increases in the number of cells that were double positive for GFP and CD4 (spleen-derived T helper lymphocytes) in the injured liver, thereby indicating that T helper lymphocytes migrated from the spleen to the liver. GFP ? T helper lymphocytes were rarely observed in the control (corn oil) mice or splenectomized CCl 4 -induced liver injury mice inoculated with GFP ? splenocytes. These results precluded the possibility that spleen-derived T helper lymphocytes observed after CCl 4 -induced liver injury were merely due to the leakage of GFP ? lymphocytes at the time of injection, and confirmed that they migrated from the spleen in response to liver injury. Swirski et al. [26] reported that splenic monocytes migrated to the injured site in response to ischaemic myocardial injury, and discovered a novel role of the spleen as a site for storage and rapid deployment of monocytes. Similarly to their findings, the present study demonstrates that the spleen functions as a site for storage and mobilization of T helper lymphocytes in response to liver injury.
Th2 lymphocytes are the main constituent of the immune environment in the spleen [27, 28] . Furthermore, in this study, we observed that most of the spleen-derived T helper cells in the liver were Th2 lymphocytes after liver injury. From our findings taken together, we propose that following liver injury, Th2-predominant splenic T lymphocytes migrate to the liver and promote liver fibrosis by modifying the Th1/Th2 balance in the liver towards Th2 dominance. Splenectomy decreases the absolute number of Th2 lymphocytes in the liver and reverses this Th1/Th2 imbalance, resulting in inhibition of liver fibrosis.
The origin of Th1 lymphocytes on liver injuries is another important issue. Lymphoid organs other than the spleen, such as marrow and thymus, may be possible sources of Th1 lymphocytes, although this is speculation. Further studies are needed to elucidate this.
Comparatively, splenectomy did not influence the progression of liver fibrosis and the liver Th1/Th2 cytokine balance in the BDL-induced liver injury model. The reason for the discrepancy between toxin-induced and cholestasisinduced liver injury models is of interest. Clinical observations have shown that the immune function is disturbed in patients with obstructive jaundice. For instance, inhibition of cellular immunity and suppression of the T lymphocyte proliferative response in jaundice were suggested [29, 30] . Animal studies have also shown that obstructive jaundice strongly influences the immune status. Katz et al. [31] demonstrated that obstructive jaundice expanded the number of regulatory T lymphocytes, which in turn suppressed bulk T cell functions in the liver. In addition, other studies have shown that BDL influenced splenocyte activity such as mitogenic response [32] . Thus, we speculate that the functional suppression of T helper cells in the liver and/or the selective depression of the lymphocytes derived from the spleen in obstructive jaundice may be the reasons why the effect of splenectomy on the development of liver fibrosis and the Th1/Th2 balance in the liver was not seen in the BDL model. However, further studies are needed to investigate this hypothesis.
In conclusion, the present study unveiled a novel role of the spleen in the progression of liver fibrosis as a site for storage and mobilization of T helper lymphocytes in response to liver injury. Further clinical studies are required to verify the beneficial effect of splenectomy on liver fibrosis in clinical situations. Our findings provide new insights into the use of immunomodulation as an effective strategy for treatment of liver fibrosis. This conclusion might be particularly important in the setting of liver transplantation to treat hepatitis C, as various immunosuppressive regimens may affect the progression of liver fibrosis differently, if the eradication of the virus is unsuccessful. A more detailed understanding of the mechanisms underlying these observations may allow the development of clinically useful immunosuppressive regimens.
